{"id":483993,"date":"2020-05-12T13:16:02","date_gmt":"2020-05-12T13:16:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=483993"},"modified":"2020-05-12T13:16:02","modified_gmt":"2020-05-12T13:16:02","slug":"catheter-related-bloodstream-infection-crbsi-epidemiology-insights-incidence-and-prevalence-trends-in-the-coming-decade","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/catheter-related-bloodstream-infection-crbsi-epidemiology-insights-incidence-and-prevalence-trends-in-the-coming-decade_483993.html","title":{"rendered":"Catheter Related Bloodstream Infection (CRBSI) Epidemiology Insights: Incidence and Prevalence Trends in the coming decade"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1589288577.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Catheter Related Bloodstream Infection (CRBSI) Epidemiology Insights: Incidence and Prevalence Trends in the coming decade\" src=\"https:\/\/www.abnewswire.com\/uploads\/1589288577.jpeg\" alt=\"Catheter Related Bloodstream Infection (CRBSI) Epidemiology Insights: Incidence and Prevalence Trends in the coming decade\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Catheter Related Bloodstream Infection (CRBSI) Epidemiology Insights<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">As per the DelveInsight\u2019s estimates, the incident population of CRBSI in the 7MM was found to be 669,393, in 2017.<\/p>\n<p>The Catheter-related bloodstream infection (CRBSI) epidemiology covered in the report provides historical as well as forecasted Catheter-related bloodstream infection (CRBSI) epidemiology scenario.<\/p><\/div>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/catheter-related-bloodstream-infection-crbsi-epidemiology?utm_source=pr&amp;utm_medium=abnewswire&amp;utm_campaign=vinita\">&#8216;Catheter-related bloodstream infection (CRBSI) &#8211; Epidemiology Forecast to 2030<\/a>&#8216; report delivers an in-depth understanding of the disease, historical and forecasted Catheter-related bloodstream infection (CRBSI) epidemiology in the 7MM.<\/p>\n<p style=\"text-align: justify;\"><strong>Geographies Covered<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The United States<\/li>\n<li>EU5 (Germany, France, Italy, Spain, and the United Kingdom)<\/li>\n<li>Japan<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Study Period: 2017-2030<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Catheter Related Bloodstream Infection (CRBSI) Epidemiology Insights <\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>As per the DelveInsight&rsquo;s estimates, the incident population of CRBSI in the 7MM was found to be 669,393, in 2017.<\/strong><\/p>\n<p style=\"text-align: justify;\">The Catheter-related bloodstream infection (CRBSI) epidemiology covered in the report provides historical as well as forecasted Catheter-related bloodstream infection (CRBSI) epidemiology scenario.<\/p>\n<p style=\"text-align: justify;\">The DelveInsight Catheter-related bloodstream infection (CRBSI) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Catheter Related Bloodstream Infection (CRBSI) Epidemiology Segmentation<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Total Incident Population of CRBSI<\/li>\n<li>Diagnosed Incidence of CRBSI by Causative Pathogens<\/li>\n<li>Total Diagnosed Incident Population of CRBSI<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Report Highlights<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>11-Year Forecast of Catheter-related bloodstream infection (CRBSI) epidemiology<\/li>\n<li>7MM Coverage<\/li>\n<li>Total Cases of Catheter-related bloodstream infection (CRBSI)<\/li>\n<li>Total Cases of Catheter-related bloodstream infection (CRBSI) according to segmentation<\/li>\n<li>Diagnosed cases of Catheter-related bloodstream infection (CRBSI)<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/catheter-related-bloodstream-infection-crbsi-epidemiology?utm_source=pr&amp;utm_medium=abnewswire&amp;utm_campaign=vinita\">Request for sample pages<\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key Assessments<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Patient Segmentation<\/li>\n<li>Disease Risk and Burden<\/li>\n<li>Risk of disease by the segmentation<\/li>\n<li>Factors driving growth in a specific patient population<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of contents <\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Catheter-Related Blood Stream Infection (CRBSI): Epidemiology Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">3. Catheter-Related Bloodstream Infection (CRBSI): Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">4. Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">5. United States Epidemiology<\/p>\n<p style=\"text-align: justify;\">6. EU5 Epidemiology<\/p>\n<p style=\"text-align: justify;\">7. APAC Epidemiology<\/p>\n<p style=\"text-align: justify;\">8. LATAM Epidemiology<\/p>\n<p style=\"text-align: justify;\">9. Middle East Epidemiology<\/p>\n<p style=\"text-align: justify;\">10. Russia Epidemiology<\/p>\n<p style=\"text-align: justify;\">11. Appendix<\/p>\n<p style=\"text-align: justify;\">11.1. Report Methodology<\/p>\n<p style=\"text-align: justify;\">12. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">13. Disclaimer<\/p>\n<p style=\"text-align: justify;\">14. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/?utm_source=pr&amp;utm_medium=abnewswire&amp;utm_campaign=vinita\">DelveInsight<\/a><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for better growth in the market.<\/p>\n<p style=\"text-align: justify;\">Browse through our vast repository from <a rel=\"nofollow\" href=\"https:\/\/delveinsight.com\/report-store.php?utm_source=pr&amp;utm_medium=abnewswire&amp;utm_campaign=vinita\">here<\/a>.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57049.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Vinita Rakheja <br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=catheter-related-bloodstream-infection-crbsi-epidemiology-insights-incidence-and-prevalence-trends-in-the-coming-decade\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=catheter-related-bloodstream-infection-crbsi-epidemiology-insights-incidence-and-prevalence-trends-in-the-coming-decade\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Catheter Related Bloodstream Infection (CRBSI) Epidemiology Insights As per the DelveInsight\u2019s estimates, the incident population of CRBSI in the 7MM was found to be 669,393, in 2017. The Catheter-related bloodstream infection (CRBSI) epidemiology covered in the report provides historical as &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/catheter-related-bloodstream-infection-crbsi-epidemiology-insights-incidence-and-prevalence-trends-in-the-coming-decade_483993.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,413,404],"tags":[],"class_list":["post-483993","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Services","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/483993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=483993"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/483993\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=483993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=483993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=483993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}